Stocks Overview

LAST PRICE
4.2800
TODAY'S CHANGE (%)
Trending Down-0.0600 (-1.3825%)

Bid / Lots
4.1400/ 5
Ask / Lots
4.5100/ 4
Open / Previous Close
4.4300 / 4.3400
Day Range
Low 4.2525
High 4.4300
52 Week Range
Low 3.2400
High 6.7700
Volume
200,745
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 4.34
Time	Volume	SCPH
09:32 ET	917	4.43
09:45 ET	200	4.4
10:01 ET	100	4.35
10:03 ET	200	4.35
10:08 ET	100	4.32
10:14 ET	100	4.325
10:15 ET	502	4.34
10:17 ET	275	4.355
10:24 ET	158	4.33
10:26 ET	100	4.33
10:28 ET	200	4.33
10:32 ET	892	4.33
10:33 ET	357	4.335
10:37 ET	300	4.315
10:42 ET	612	4.33
10:44 ET	249	4.34
10:48 ET	102	4.34
10:51 ET	930	4.35
10:53 ET	170	4.36
10:55 ET	100	4.37
11:02 ET	555	4.38
11:04 ET	500	4.37
11:06 ET	210	4.37
11:15 ET	692	4.33
11:18 ET	700	4.32
11:22 ET	100	4.315
11:24 ET	3103	4.3
11:26 ET	2898	4.2999
11:36 ET	100	4.315
11:38 ET	318	4.3
11:44 ET	703	4.32
11:45 ET	100	4.31
11:49 ET	100	4.31
11:56 ET	300	4.32
12:02 ET	200	4.32
12:03 ET	400	4.32
12:05 ET	400	4.32
12:07 ET	100	4.32
12:09 ET	664	4.325
12:16 ET	100	4.33
12:20 ET	500	4.335
12:39 ET	100	4.33
12:41 ET	100	4.33
12:50 ET	1200	4.338
12:52 ET	13916	4.33
12:54 ET	15740	4.345
12:56 ET	717	4.346
12:59 ET	200	4.35
01:03 ET	5281	4.35
01:06 ET	918	4.35
01:10 ET	9648	4.35
01:14 ET	415	4.36
01:19 ET	100	4.38
01:24 ET	677	4.3615
01:26 ET	900	4.36
01:28 ET	864	4.351
01:30 ET	2410	4.3248
01:32 ET	2311	4.3126
01:35 ET	1116	4.3148
01:37 ET	1000	4.3126
01:39 ET	472	4.3369
01:42 ET	4126	4.3048
01:44 ET	1199	4.3
01:46 ET	100	4.31
01:51 ET	1200	4.31
01:53 ET	100	4.31
01:55 ET	1859	4.28
01:57 ET	1200	4.2785
02:00 ET	4396	4.272
02:02 ET	5100	4.268
02:04 ET	200	4.265
02:06 ET	100	4.28
02:08 ET	2394	4.305
02:13 ET	600	4.29
02:15 ET	300	4.28
02:22 ET	100	4.29
02:24 ET	3049	4.28
02:26 ET	100	4.29
02:36 ET	100	4.28
02:38 ET	200	4.28
02:42 ET	100	4.27
02:45 ET	100	4.28
02:51 ET	1306	4.27
02:54 ET	1317	4.3
02:58 ET	4994	4.32
03:00 ET	500	4.32
03:02 ET	700	4.31
03:03 ET	524	4.31
03:05 ET	300	4.31
03:07 ET	200	4.315
03:09 ET	100	4.315
03:12 ET	100	4.315
03:14 ET	500	4.31
03:16 ET	100	4.31
03:18 ET	900	4.3
03:20 ET	300	4.3
03:21 ET	200	4.3
03:23 ET	500	4.3
03:25 ET	802	4.3
03:27 ET	600	4.3
03:34 ET	1498	4.3
03:36 ET	300	4.29
03:38 ET	200	4.29
03:39 ET	1011	4.29
03:41 ET	200	4.285
03:43 ET	200	4.285
03:45 ET	300	4.285
03:48 ET	1383	4.27
03:50 ET	400	4.27
03:52 ET	400	4.27
03:54 ET	3142	4.27
03:56 ET	500	4.27
03:57 ET	2351	4.265
03:59 ET	24639	4.28

Data delayed at least 15 minutes.

No documents available

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesSCPH scPharmaceuticals Inc	214.1M	-2.7x	---
United StatesBSEM Biostem Technologies Inc	161.2M	29.6x	---
United StatesASPI ASP Isotopes Inc	206.7M	-4.9x	---
United StatesPGEN Precigen Inc	257.0M	-1.7x	---
United StatesTELO Telomir Pharmaceuticals Inc	160.8M	-7.9x	---
United StatesHCIL Hongchang International Co Ltd	140.1M	-450.0x	---
As of 2024-10-05

scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infuser. FUROSCIX is a formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self- administered subcutaneously via a single-use, disposable and wearable on-body delivery system. The Companay’s pipeline programs include SCP-111 (furosemide injection) 80mg/mL is an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home.

Contact Information

Headquarters: 25 Burlington Mall Road, Suite 203BURLINGTON, MA, United States 01803
Phone: 617-517-0730
Fax: 302-655-5049

Executives

Independent Chairman of the Board: Jack Khattar
President, Chief Executive Officer, Director: John Tucker
Chief Financial Officer: Rachael Nokes
Independent Director: William Abraham
Independent Director: Mette Agger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$214.1M
Revenue (TTM)	$24.0M
Shares Outstanding	50.0M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.14
EPS	$-1.56
Book Value	$1.03
P/E Ratio	-2.7x
Price/Sales (TTM)	8.9
Price/Cash Flow (TTM)	---
Operating Margin	-251.09%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

scPharmaceuticals Inc
NASDAQ:SCPHUnited States

Search Criteria

Charts

Recent News

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar